References
- Fuhrman K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6: 219–224
- Kitzmiller J L, Gavin L A, Gin G D, Jovanovic-Peterson L, Main E K, Zigrang W D. Preconception care of diabetes: Glycemic control prevents congenital anomalies. JAMA 1991; 265: 731–736
- Pettit D J, Knowles W C, Baird H R, Bennett P H. Gestational diabetes: Infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in Pima Indians. Diabetes Care 1980; 3: 458–464
- Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynecol 1972; 112: 213–220
- Langer O, Mazze R. The relationship between large for gestational age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol 1988; 159: 1478–1483
- Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus—how tight is tight enough: Small for gestational age versus large for gestational age. Am J Obstet Gynecol 1989; 161: 646–653
- Jovanovic-Peterson L, Peterson C M, Reed G F, Metzger B E, Mills J L, Knopp R H, Aarons J H. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991; 164: 103–111
- Landon M B, Gabbe S G, Piana R, Mennuti M T, Main E K. Neonatal morbidity in pregnancy complicated by diabetes mellitus: Predictive value of maternal glycemic profiles. Am J Obstet Gynecol 1987; 156: 1089–1095
- Anderson J H, Jr, Brunelle R L, Keohane P, Koivisto V A, Trautmann M E, Vignat L, DiMarchi R. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46: 265–270
- Jovanovic L, Ilic S, Pettitt D, Hugo K, Gutierrez M, Bowsher R, Bastyr E. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999; 22: 1422–1427
- Bhattacharyya A, Brown S, Hughes S, Vice P A. Insulin lispro and regular insulin in pregnancy. Q J Med 2001; 94: 255–260
- Cypryk K, Sobczak M, Pertynska-Marczewska M, Zawodniak-Szalapska M, Szymczak W, Wilczynski J, Lewinski A. Pregnancy complications and perinatal outcome in diabetic women treated with humalog or regular human insulin during pregnancy. Med Sci Monit 2004; 10: 29–32
- Persson B, Swahn M L, Hjertberg R, Hanson U, Nord E, Norlander E, Hansson L O. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract 2002; 58: 115–121
- Masson E A, Patmore J E, Brash P D, Baxter M, Caldwell G, Gallen W, Price P A, Vice P A, Walker J D, Lindow S W. Pregnancy outcome in type 1 diabetes mellitus treated with insulin lispro. Diabet Med 2003; 20: 46–50
- Scherbaum W A, Lankisch M R, Pawlowski B, Somville T. Insulin lispro in pregnancy—retrospective analysis of 33 cases and matched controls. Exp Clin Endocrinol Diabet 2002; 110: 6–9
- Wyatt J W, Frias L, Hoyme H E, Jovanovic L, Kaaja R, Brown F, Garg S, Lee-Paritz A, Seely E W, Kerr L, et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 2005; 22: 803–807